North America holds a significant share of the Oxytocin Receptor Antagonists Market due to its well-established healthcare systems, rising awareness of maternal and neonatal health, and ongoing advancements in reproductive medicine. The region continues to witness increasing demand for effective therapies to manage preterm labor, supported by strong research activities, favorable healthcare...